EICHOR
● Active Not Recruiting
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Condition: Crohn's Disease · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (579)
| Digestive Health Specialists of the Southeast | Dothan, Alabama, United States | — |
| Internal Medicine Center | Mobile, Alabama, United States | — |
| University of Arizona | Tucson, Arizona, United States | — |
| Advanced Research Center Inc | Anaheim, California, United States | — |
| Paul Wallace MD | Beverly Hills, California, United States | — |
| University Of California San Diego | La Jolla, California, United States | — |
| Om Research LLC | Lancaster, California, United States | — |
| Allameh Medical Corp | Mission Viejo, California, United States | — |
| United Gastroenterologists | Murrieta, California, United States | — |
| Clinnova Research | Orange, California, United States | — |
| Inland Empire Liver Foundation | Rialto, California, United States | — |
| UC Davis Medical Center | Sacramento, California, United States | — |
+ 567 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03466411